ASSURANT INC
For the period ended Mar 31, 2025. Filed May 8, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 8, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1A. Risk Factors
Certain factors may have a material adverse effect on our business, financial condition, results of operations and cash flows, and you should carefully consider them. It is not possible to predict or identify all such factors. For a discussion of potential risks or uncertainties affecting us, please refer to the information under the heading “Item 1A—Risk Factors” in our 2024 Annual Report. Additional risks and uncertainties that are not yet identified or that we currently believe to be immaterial may also materially harm our business, financial condition, results of operations and cash flows.
Issuer Purchases of Equity Securities:
| (In millions, except number of shares and per share amounts) | ||||
|---|---|---|---|---|
| Period in 2025 | TotalNumber ofShares Purchased | Average PricePaid Per Share | Total Number of SharesPurchased as Part ofPublicly AnnouncedPrograms (1) | ApproximateDollar Value ofShares thatMay Yet bePurchasedUnder thePrograms (1) |
| January 1 - January 31 | 91,518 | $210.08 | 91,518 | $355.3 |
| February 1 - February 28 | 58,295 | 209.26 | 58,295 | 343.1 |
| March 1 - March 31 | 149,133 | 208.19 | 149,133 | 312.1 |
| Total | 298,946 | $208.98 | 298,946 | $312.1 |
(1)Shares repurchased pursuant to the November 2023 publicly announced share repurchase authorization of up to $600.0 million aggregate cost at purchase of outstanding common stock. As of March 31, 2025, $312.1 million aggregate cost at purchase remained unused under the repurchase authorization.
Rule 10b5-1 and non-Rule 10b5-1 Trading Arrangements
On March 10, 2025, Keith W. Demmings, our President and Chief Executive Officer, and a director on our Board, adopted a plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a “Plan”). Mr. Demmings’s Plan provides for the sale of up to 18,000 shares of our common stock, and terminates on the earlier of: (i)February 27, 2026, (ii) the date all shares are sold thereunder or (iii) such date that the Plan is otherwise terminated according to its terms.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.